Lunit Advances to Stage 2 of Australia's National Breast Can

After a successful stage 1, Lunit INSIGHT MMG moves to prospective validation in Australia's BreastScreen NSW Machine Reading Solution Project SEOUL, South Korea, Dec. 11, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced its progression to the second stage of the BreastScreen NSW (BSNSW) Machine Reading Solution Project....

Related Keywords

Australia , South Korea , Seoul , Soult Ukpyolsi , Brandon Suh , Prnewswire Lunit , Lancet Digital Health , Cancer Institute , Breastscreen Australia Program , Reading Solution , Machine Reading Solution , New South Wale , Reading Solution Project , Clinical Oncology ,